• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,488.96 1,073.61
( 1.42%)
Global Indices
Nasdaq
50,600.73 294.06
(0.58%)
Dow Jones
7,493.73 27.01
(0.36%)
Hang Seng
65,182.04 1,842.97
(2.91%)
Nikkei 225
10,474.02 30.55
(0.29%)
Forex
USD-INR
96.29 -0.42
(-0.43%)
EUR-INR
111.82 -0.44
(-0.39%)
GBP-INR
129.28 -0.40
(-0.31%)
JPY-INR
0.61 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

ANG Lifesciences India reports consolidated net loss of Rs 4.75 crore in the December 2025 quarter
Feb 15,2026
Net Loss of ANG Lifesciences India reported to Rs 4.75 crore in the quarter ended December 2025 as against net loss of Rs 5.19 crore during the previous quarter ended December 2024. Sales declined 24.26% to Rs 18.73 crore in the quarter ended December 2025 as against Rs 24.73 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales18.7324.73 -24
OPM %-14.36-8.69 -
PBDT-4.45-4.42 -1
PBT-5.96-6.38 7
NP-4.75-5.19 8